Similar to This
Previous
Profile picture of STAT
STAT Oct 19
Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more
statnews.com/pharmalot/2026/10/19/roche-investments-in-germany-gilead-bowel-disease-drug/
Pharmalittle: We’re reading about Roche investments in Germany ...
0 similar articles
0
0
Profile picture of Quartz
Quartz
Credibility B+
 Oct 16
Gilead is teaming up with Vir on solid tumor cancer drugs in a deal worth up to $1.9 billion
qz.com/gilead-vir-biotechnology-solid-tumor-cancer-deal-101526
Gilead is teaming up with Vir on solid tumor cancer drugs in a deal worth ...
3 similar articles
0
0
Profile picture of STAT
STAT Sep 24
Kyverna’s cell therapy shows lasting autoimmune benefit: Today's biotech news includes FDA adcomm backing Grail's cancer blood test ...
statnews.com/2026/09/24/biotech-news-kyverna-cell-therapy-shows-lasting-autoimmune-benefit/
Kyverna’s cell therapy shows lasting autoimmune benefit
0 similar articles
0
0
Profile picture of STAT
STAT Sep 24
Why Gilead can’t stop talking about its ambitions in immunology: In this week's edition of "Adam's Biotech Scorecard," Adam also looks ahead ...
statnews.com/2026/09/24/gilead-immunology-inflammation-biotech-moderna-merck/
Why Gilead can’t stop talking about its ambitions in immunology
0 similar articles
0
0
Profile picture of STAT
STAT Aug 04
Three biotechs with three news updates: Today's biotech news includes Gilead wins case over its HIV medicine, Eli Lilly to expand retatrutide access ...
statnews.com/2026/08/04/biotech-news-gilead-wins-case-that-scrutinized-pace-of-drug-development/
Three biotechs with three news updates
0 similar articles
0
0
Profile picture of STAT
STAT Jun 09
Gilead and Merck’s latest trial success and flop: Today's biotech news includes AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition ...
statnews.com/2026/06/09/biotech-news-gilead-and-merck-latest-trial-success-and-flop/
Gilead and Merck’s latest trial success and flop
0 similar articles
0
0
Profile picture of deraktionaer.de
deraktionaer.de
C
 May 08
Gilead: Expectations exceeded - | why the stock still falls: Gilead Sciences exceeds Q1 revenue | and profit expectations, yet the stock falls.
deraktionaer.de/artikel/pharma-biotech/gilead-erwartungen-uebertroffen-darum-faellt-die-aktie-trotzdem-20400637.html
Gilead: Expectations exceeded - | why the stock still falls
Key FactsGilead shares fall despite beating quarterly expectations
May 8, 2026 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de
  • In the first quarter, Gilead’s revenue rose four percent to $7.0 billion, exceeding the expected $6.9 billion.

  • Earnings per share reached $2.03 instead of the expected $1.90.

  • Gilead raised its product-revenue forecast to $30.0–30.4 billion, but expects an adjusted loss per share of $3.25–2.85.

  • The company attributes the expected loss to special effects from numerous acquisitions, including announced deals with Arcellx, Tubulis, and Ouro Medicines.
0
0
Profile picture of STAT
STAT Apr 08
Terns’ drug may not be as competitive as many initially thought: Today's biotech news covers a controversial class of drugs for Duchenne ...
statnews.com/2026/04/08/biotech-news-terns-drug-may-not-be-as-competitive-as-initially-believed/
Terns’ drug may not be as competitive as many initially thought
0 similar articles
0
0
0
0
Profile picture of STAT
STAT Apr 07
Gilead to buy cancer biotech Tubulis for more than $3 billion: Tubulis, based in Munich, is developing antibody-drug conjugates, which are next-generation ...
statnews.com/2026/04/07/gilead-sciences-acquisition-tubulis-adcs-chemotherapy-cancer/
Gilead to buy cancer biotech Tubulis for more than $3 billion
0 similar articles
0
0
Profile picture of deraktionaer.de
deraktionaer.de
C
 Apr 07
For up to $5 billion! Gilead acquires Munich-based biotech company: Gilead Sciences is acquiring the Munich-based biotech company Tubulis for up to $5 billion to ...
deraktionaer.de/artikel/pharma-biotech/fuer-bis-zu-5-milliarden-dollar-gilead-kauft-biotech-firma-aus-muenchen-20398537.html
For up to $5 billion! Gilead acquires Munich-based biotech company
0 similar articles
0
0
Profile picture of STAT
STAT Mar 31
Psychedelic biotechs face scrutiny over YouTube promos: Today's biotech news covers Biogen and Eli Lilly making takeover moves, Doctors Without Borders ...
statnews.com/2026/03/31/biotech-news-psychedelic-startups-face-scrutiny-over-youtube-promo/
Psychedelic biotechs face scrutiny over YouTube promos
0 similar articles
0
0
0
0
Profile picture of STAT
STAT Mar 24
Gilead to acquire immunology biotech, offers lifeline to Galapagos: Today's biotech news includes Gilead Sciences' acquisition of Ouro ...
statnews.com/2026/03/24/gilead-ouro-galapagos-merck-quotient-ibd-readout-newsletter/
Gilead to acquire immunology biotech, offers lifeline to Galapagos
0 similar articles
0
0
Profile picture of deraktionaer.de
deraktionaer.de
C
 Oct 15 25
Gilead partner Tubulis: Record financing for German biotech hopeful: Tubulis secures record Series C financing of $361 million for cancer ADCs.
deraktionaer.de/artikel/pharma-biotech/gilead-partner-tubulis-rekord-finanzierung-fuer-deutsche-biotech-hoffnung-20388328.html
Gilead partner Tubulis: Record financing for German biotech hopeful
0 similar articles
0
2
Profile picture of The Philadelphia Inquirer
The Philadelphia Inquirer
C+
 Aug 22 25
Penn spinout Interius BioTherapeutics is being sold to Kite Pharma for $350 million
inquirer.com/health/upenn-spinout-interius-biotherapeutics-sold-kite-gilead-20250821.html
Penn spinout Interius BioTherapeutics is being sold to Kite Pharma for ...
0 similar articles
0
0
0
3 0
Next